Bio-Techne
TECH
530 hedge funds and large institutions have $12.3B invested in Bio-Techne in 2023 Q4 according to their latest regulatory filings, with 80 funds opening new positions, 211 increasing their positions, 172 reducing their positions, and 71 closing their positions.
69% more call options, than puts
Call options by funds: $28M | Put options by funds: $16.6M
29% more funds holding in top 10
Funds holding in top 10: 7 → 9 (+2)
23% more repeat investments, than reductions
Existing positions increased: 211 | Existing positions reduced: 172
19% more capital invested
Capital invested by funds: $10.4B → $12.3B (+$1.95B)
13% more first-time investments, than exits
New positions opened: 80 | Existing positions closed: 71
4.7% more ownership
Funds ownership: 96.19% → 100.89% (+4.7%)
0% more funds holding
Funds holding: 529 → 530 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$321M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$72.1M |
| 3 |
SCM
Snyder Capital Management
San Francisco,
California
|
+$55.2M |
| 4 |
Brown Advisory
Baltimore,
Maryland
|
+$48.9M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$48.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$57.1M |
| 2 |
Westfield Capital Management
Boston,
Massachusetts
|
-$47.6M |
| 3 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
-$38M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$29M |
| 5 |
OCBV
Ownership Capital B.V.
Amsterdam,
Netherlands
|
-$25.8M |
TECH Hedge Fund Activity: Q4 2023 in Review
530 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q4 2023, worth a combined $12.3B — up 19% from $10.4B a quarter earlier.
Buyers outnumbered sellers: 80 funds opened new TECH positions and 71 closed out — a net gain of 9 holders — while 211 added to existing stakes and 172 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $321M. The largest seller was T. Rowe Price Associates, cutting an estimated $57.1M.
- 530 institutional investors held Bio-Techne (TECH) as of Q4 2023, up from 529 in Q3 2023.
- Funds reported $12.3B of Bio-Techne stock for Q4 2023, up 19% quarter-over-quarter.
- 80 funds opened new Bio-Techne positions in Q4 2023 and 71 closed out, a net change of +9 holders.
- The largest Bio-Techne buyer in Q4 2023 was Morgan Stanley, an estimated $321M added.
- The largest Bio-Techne seller in Q4 2023 was T. Rowe Price Associates, an estimated $57.1M sold.
Based on aggregated 13F filings for Q4 2023.